Use of neuromodulation for treatment resistant schizophrenia and depression
Document Type
News Article
Abstract
Clinical research center for neuromodulation is working on three main projects currently. Using neuromodulation for treatment resistant disorders like Schizophrenia and depression and assessing the mechanistic basis of treatment is the focus of the center.
The main three projects are:
- Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: multi-site parallel arm double-blind randomized sham-controlled study.
- Evaluating the clinical efficacy and neurobiological correlates of sequential treatment with tDCS primed iTBS and ECT in treatment-resistant depression
- Identification of resting brain functional connectivity markers of response to continuous Theta Burst Stimulation and cathodal transcranial Direct Current Stimulation in schizophrenia patients with persistent auditory hallucinations
- https://wellcomeopenresearch.org/articles/7-242
- https://wellcomeopenresearch.org/articles/7-212
- https://pubmed.ncbi.nlm.nih.gov/34789940/
Link to publications : https://scholar.google.co.in/citations?hl=en&user=CFPTseIAAAAJ&view_op=list_works
Publication Date
Spring 10-1-2022
Recommended Citation
Shenoy, Sonia Dr, "Use of neuromodulation for treatment resistant schizophrenia and depression" (2022). Health collection. 70.
https://impressions.manipal.edu/health-collection/70
COinS
